Innovative Solutions in Immunology, Radiopharmaceuticals, and Immunotherapies

The Emerging Therapeutics Stream at PEGS 2025 offers an in-depth exploration of cutting-edge advancements across three pivotal tracks. The Biologics for Immunology Indications track focuses on preclinical research and innovative strategies for complex immunological conditions, from autoimmunity to rare diseases, emphasizing novel therapeutic approaches and early-stage research. The Radiopharmaceuticals Therapies track investigates the forefront of radionuclide therapy, combining targeted molecules with radioisotopes for precise cancer treatment, addressing advancements, challenges, and clinical considerations. Lastly, the Next Generation Immunotherapies track covers the latest in target discovery and validation, including emerging technologies and novel targets for cancer and other diseases. Together, these tracks provide a comprehensive view of therapeutic innovations driving the future of biologic and targeted treatments.

Conferences Include:

May 12-13

Biologics for Immunology Indications

May 13-14

Radiopharmaceutical Therapies

May 15-16

Next-Generation Immunotherapies

Keynote and Featured Speakers:

AI in Biopharmaceutical Development: What Could Go Wrong?
Christopher P. Calderon, PhD, Associate Research Professor, Chemical and Biological Engineering, University of Colorado

Advancing Antibody and Nanobody Humanization through Computational Design
Pietro Sormanni, PhD, Group Leader, Royal Society University Research Fellow, Chemistry of Health, Yusuf Hamied Department of Chemistry, University of Cambridge

Generative AI to Accelerate Prediction and Design in Biomedicine and Sustainability
Debora S. Marks, PhD, Associate Professor, Systems Biology, Harvard Medical School

2025 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies
• Engineering Bispecific and Multifunctional Antibodies

• Advances in Immunotherapy
• Engineering Cell Therapies
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Maximizing Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI/ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Immunology Indications
• Radiopharmaceutical Therapies
• Next-Generation Immunotherapies

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI/ML Tools
• Machine Learning for Protein Engineering